PURPOSE: Cigarette smoking is the major cause of laryngeal cancer. The time to first cigarette after waking in the morning is a behavior associated with several dimensions of nicotine dependence including the dose of smoke uptake. We hypothesized that a short TTFC increases the risk of laryngeal cancer. METHODS: The analysis was based on data from a hospital-based case-control study of laryngeal cancer. The current analysis included only subjects who were ever cigarette smokers, including 570 cases and 343 controls (832 whites and 81 blacks). Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression adjusting for smoking history and other potential confounders. Incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute from 1975 to 2006 were analyzed for trends in laryngeal cancer. RESULTS: There was a dose-response relationship between TTFC and supraglottic cancer. Compared to subjects who smoked more than 60 min after waking, the adjusted odds ratio was 1.51 (95% CI, 0.63-3.61) for 30-60 min and 3.13 (95% CI, 1.56-6.30) for 0-30 min. No association was observed between TTFC and cancer of the glottis. In blacks, the TTFC was not associated with the risk of laryngeal cancer. Trends in SEER rates were similar for cancer of the glottis and supraglottis, indicating that the site-specific differences were not affected by unknown confounders. CONCLUSION: A nicotine dependence behavior that is associated with cigarette smoke uptake increases the risk of cancer of the supraglottis larynx, but not glottis larynx.
PURPOSE: Cigarette smoking is the major cause of laryngeal cancer. The time to first cigarette after waking in the morning is a behavior associated with several dimensions of nicotine dependence including the dose of smoke uptake. We hypothesized that a short TTFC increases the risk of laryngeal cancer. METHODS: The analysis was based on data from a hospital-based case-control study of laryngeal cancer. The current analysis included only subjects who were ever cigarette smokers, including 570 cases and 343 controls (832 whites and 81 blacks). Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression adjusting for smoking history and other potential confounders. Incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute from 1975 to 2006 were analyzed for trends in laryngeal cancer. RESULTS: There was a dose-response relationship between TTFC and supraglottic cancer. Compared to subjects who smoked more than 60 min after waking, the adjusted odds ratio was 1.51 (95% CI, 0.63-3.61) for 30-60 min and 3.13 (95% CI, 1.56-6.30) for 0-30 min. No association was observed between TTFC and cancer of the glottis. In blacks, the TTFC was not associated with the risk of laryngeal cancer. Trends in SEER rates were similar for cancer of the glottis and supraglottis, indicating that the site-specific differences were not affected by unknown confounders. CONCLUSION: A nicotine dependence behavior that is associated with cigarette smoke uptake increases the risk of cancer of the supraglottis larynx, but not glottis larynx.
Authors: David I Conway; Mia Hashibe; Paolo Boffetta; Victor Wunsch-Filho; Joshua Muscat; Carlo La Vecchia; Deborah M Winn Journal: Oral Oncol Date: 2009-05-12 Impact factor: 5.337
Authors: Matthew J Grainge; Lion Shahab; David Hammond; Richard J O'Connor; Ann McNeill Journal: Drug Alcohol Depend Date: 2009-05 Impact factor: 4.492
Authors: Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Mia Hashibe; Paul Brennan; Shu-Chun Chuang; Stefania Boccia; Xavier Castellsague; Chu Chen; Maria Paula Curado; Luigino Dal Maso; Alexander W Daudt; Eleonora Fabianova; Leticia Fernandez; Victor Wünsch-Filho; Silvia Franceschi; Richard B Hayes; Rolando Herrero; Karl Kelsey; Sergio Koifman; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Juan J Lence; Dana Mates; Elena Matos; Ana Menezes; Michael D McClean; Joshua Muscat; Jose Eluf-Neto; Andrew F Olshan; Mark Purdue; Peter Rudnai; Stephen M Schwartz; Elaine Smith; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Renato Talamini; Qingyi Wei; Deborah M Winn; Oxana Shangina; Agnieszka Pilarska; Zuo-Feng Zhang; Gilles Ferro; Julien Berthiller; Paolo Boffetta Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-02-03 Impact factor: 4.254
Authors: Joshua E Muscat; Steven D Stellman; Ralph S Caraballo; John P Richie Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-12 Impact factor: 4.090
Authors: Darla E Kendzor; Michael S Businelle; Lorraine R Reitzel; Debra M Rios; Taneisha S Scheuermann; Kim Pulvers; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2013-12-03 Impact factor: 4.244
Authors: Gideon St Helen; Neal L Benowitz; Jasjit S Ahluwalia; Rachel F Tyndale; Newton Addo; Steven E Gregorich; Eliseo J Pérez-Stable; Lisa Sanderson Cox Journal: J Natl Med Assoc Date: 2019-05-11 Impact factor: 1.798
Authors: Kristin A Guertin; Fangyi Gu; Sholom Wacholder; Neal D Freedman; Orestis A Panagiotou; Carolyn Reyes-Guzman; Neil E Caporaso Journal: PLoS One Date: 2015-05-18 Impact factor: 3.240
Authors: Tamer A Mesallam; Mohamed Farahat; Rasha Shoeib; Sami Alharethy; Abdulaziz Alshahwan; Thomas Murry; Khalid Almalkia Journal: Ann Saudi Med Date: 2015 Mar-Apr Impact factor: 1.526